Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
News
0
d
|
$44.03
0.59%
-5.75%
970K
|
Health Technology
(0.0% 1d) (-23.0% 1m) (208.4% 1y) (0.0% 2d) (0.2% 3d) (-17.7% 7d) (-100.0% volume)
Earnings Calendar:
Market Cap: $ 3,592,675,490
http://www.biohavenpharma.com
Sec Filling | Patents | 647 employees
(US) Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT.
neurological
add to watch list Paper trade email alert is off
Press-releases
Biohaven Announces Proposed Public Offering of Common Shares
Published: 2024-04-17 (Crawled : 20:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
| Email alert
Add to watchlist
offering
Biohaven Showcases Innovative Neuroscience Portfolio with 20 Presentations at the 2024 American Academy of Neurology (AAN) Annual Meeting and Provides Other Business Updates
Published: 2024-04-13 (Crawled : 16:20) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
| Email alert
Add to watchlist
business neurology meeting
Biohaven Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Developments
Published: 2024-02-29 (Crawled : 21:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: -1.37%
H: 9.06%
C: 4.34%
business year financial results
Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therapeutic Indications in Neuroscience, Immunology and Oncology
Published: 2024-01-08 (Crawled : 12:30) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: 0.77%
H: 9.9%
C: 9.65%
ABBV | $164.25 1.05% -0.76% 4M
|
Health Technology
|
| O: 0.52%
H: 0.0%
C: 0.0%
immunology
Biohaven to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-02 (Crawled : 12:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: -1.66%
H: 1.47%
C: -0.38%
conference
Biohaven Presents Expanded EEG and Safety Data for BHV-7000 at the American Epilepsy Society Annual Meeting
Published: 2023-12-01 (Crawled : 22:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
| Email alert
Add to watchlist
bhv-7000 meeting
Biohaven Reports Third Quarter 2023 Financial Results and Recent Business Developments
Published: 2023-11-14 (Crawled : 21:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: -0.54%
H: 4.15%
C: -1.92%
business financial results
Biohaven Announces Closing of Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares
Published: 2023-10-05 (Crawled : 20:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: 2.07%
H: 0.0%
C: -2.56%
offering
Biohaven Announces Pricing of $225 Million Public Offering of Common Shares
Published: 2023-10-03 (Crawled : 04:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: -3.61%
H: 2.41%
C: 0.09%
offering
Biohaven Completes Enrollment in Pivotal Phase 3 Study of Taldefgrobep Alfa in Spinal Muscular Atrophy
Published: 2023-09-14 (Crawled : 11:00) - prnewswire.com
BHVN | News 0 d | $44.03 0.59% -5.75% 970K
|
Health Technology
|
| O: 0.74%
H: 1.91%
C: 1.3%
study
Last 15 days Sec forms
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 56% | 44% |
Top 10 Gainers
INVO | $1.76 131.58% 56.82% 230M
|
Health Technology
SINT | $0.0365 59.39% 37.26% 470M
|
Health Technology
WISA 4 | $9.19 50.66% 33.7% 65M
|
Electronic Technology
EDBL | News | $6.73 47.91% 32.39% 13M
|
GCTK | $0.715 36.27% 26.62% 640K
|
Manufacturing
TCON | $2.33 36.26% 26.61% 2M
|
Health Technology
TIRX | $0.48 6.43% 24.58% 4.8M
|
KZIA | $0.38 30.58% 23.42% 300K
|
Health Technology
VNDA | News | $5.23 29.14% 22.56% 24M
|
Health Technology
ATNF | $1.91 29.05% 22.51% 310K
|
Last 48 Hours Insiders Buying
IZEA | $2.5 -2.4% 8.6K
|
Technology Services
|
00:00
RKT P 383 | $11.38 -0.52% 1.05% 1.4M
|
Finance
|
22:30
CTRN P 18090 | $22.46 -1.01% -1.02% 55K
|
Retail Trade
|
22:00
BRN P 10650 | $2.795 2.38% 0.18% 35K
|
Energy Minerals
|
21:00
NEOG P 10000 | $12.14 -0.16% -0.16% 3.1M
|
Health Technology
|
16:30
RMCF | $3.51 -3.7% -3.85% 3.8K
|
Consumer Non-Durables
|
20:10